相关实验视频
Updated: Jul 26, 2026
09:12
MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells
Published on: December 21, 2011
18.8K
一个全基因组的shRNA屏幕揭示了NK细胞激活受体的新型潜在连接体
Paolo Romania1, Loredana Cifaldi1,2, Paula Gragera1
1Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Frontiers in immunology
|July 3, 2025
概括
研究人员确定了胎盘特异性1 (PLAC1) 作为自然杀手细胞激活受体 (NKARs) 的新联体. 这一发现可能通过向PLAC1来增强NK细胞基础免疫疗法,以改善癌症治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 自然杀手 (NK) 细胞对于免疫反应对抗病毒感染和瘤至关重要.
- NK细胞活动是由受体及其连接体介导的激活和抑制信号的平衡来调节的.
- 许多NK细胞激活受体 (NKARs) 的配体仍然未被确定,限制了治疗策略.
研究的目的:
- 为了确定参与NK细胞中介细胞毒性的NKARs的新型配体.
- 研究胎盘特异性1 (PLAC1) 基因在NK细胞功能和癌症中的作用.
- 探索PLAC1作为增强NK细胞基础免疫疗法的治疗标的潜力.
主要方法:
- 使用K562细胞和初级NK细胞进行全基因组shRNA选,以确定影响NK细胞细胞毒性的基因.
- 包括PLAC1在内的候选基因的功能验证通过基因沉默和过度表达研究进行.
- 使用融合蛋白试验评估了PLAC1和NKAR之间的相互作用;从TCGA和HPA数据库分析了基因表达数据.
主要成果:
- 十个候选基因的下调,特别是PLAC1,显著地保护了目标细胞免受NK细胞溶解.
- 过度表达PLAC1增强了NK细胞降粒和证明与多个NKARs (NKG2D,DNAM1,NKp44,NKp30) 的相互作用.
- PLAC1通常在大多数组织中被静止,但在各种瘤中过度表达,预后意义因癌症类型而异.
结论:
- 胎盘特异性1 (PLAC1) 被确定为NKARs的一个新型潜在连接体.
- 对于开发增强NK细胞识别和改善免疫疗法的策略来说,PLAC1是一个有前途的目标.
- 向PLAC1可以提高NK细胞治疗各种癌症的疗效.
相关概念视频
01:25Immune Surveillance by NK Cells and Phagocytes
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...